You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VP-16

Showing 1 - 25 of 6,249
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2023

Ovarian Cancer, Epithelial Trial in Nanjing (Envafolimab, Lenvatinib, VP-16)

Not yet recruiting
  • Ovarian Cancer, Epithelial
  • Nanjing, Jiangsu, China
    Zhongda Hospital
Jun 13, 2022

HER2-positive Breast Cancer Trial (Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab))

Not yet recruiting
  • HER2-positive Breast Cancer
  • Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab)
  • (no location specified)
Jul 20, 2023

Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Unilateral Retinoblastoma Trial (Biospecimen Collection,

Not yet recruiting
  • Bilateral Retinoblastoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • (no location specified)
Aug 17, 2022

HIV, Lymphoma Trial in Zhanjiang (KL-7SHRNA injection solution)

Recruiting
  • HIV Infections
  • Lymphoma
  • KL-7SHRNA injection solution
  • Zhanjiang, Guangdong, China
    Affiliated hospital of Guangdong medical university
Jun 24, 2023

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Duarte, California
  • +3 more
Oct 24, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial

Recruiting
  • ENSAT Stage I Adrenal Cortex Carcinoma
  • +2 more
  • Ann Arbor, Michigan
  • +3 more
Dec 13, 2022

Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)

Recruiting
  • Chidamide
  • Hemophagocytic Lymphohistiocytosis
  • Chidamide combines with VP-16 and methylprednisolone
  • Beijing, Beijing, China
    Beijing Friendship Hospital
Nov 29, 2021

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Extensive Stage Lung Small Cell Carcinoma Trial in Duarte (Atezolizumab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)

Recruiting
  • Hemophagocytic Syndrome
  • Chongqing, China
    The Second affiliated Hosptial of Chongqing medical University
Jun 28, 2023

Extensive Stage Lung Small Cell Carcinoma Trial in Buffalo (Atezolizumab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Atezolizumab
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 9, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +2 more
  • (no location specified)
Nov 14, 2022

Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

Recruiting
  • Anaplastic Ependymoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • Induction Chemotherapy
  • +3 more
  • Palo Alto, California
  • +5 more
Nov 29, 2022

Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

Not yet recruiting
  • Neuroendocrine Carcinoma of the Bladder
  • Bladder Cancer
  • (no location specified)
Oct 14, 2023

Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Seattle

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 13, 2022

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

Withdrawn
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

Recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Basiliximab
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jun 16, 2022

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Ovarian Cancer Trial in Shanghai (Etoposide, Cyclophosphamide, Carboplatin)

Active, not recruiting
  • Ovarian Cancer
  • Etoposide, Cyclophosphamide, Carboplatin
  • Shanghai, Shanghai, China
    Wu Xiaohua
Jul 25, 2022

AML, Adult Trial in Hangzhou (QN-030a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022